Sanofi SA shareholders will vote at the company’s Annual General Meeting on April 29, 2026 on a board proposal to appoint Christel Heydemann as an independent director, alongside proposals to renew the mandates of directors Christophe Babule and Jean-Paul Kress. Shareholders are recommended to vote yes on the proposals.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sanofi SA published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202603050316OMX_____CNEWS_EN_GNW1001168369_en) on March 05, 2026, and is solely responsible for the information contained therein.
Comments